Revolution Medicines, Inc. (RVMD) is listed on NASDAQ in Biotech Stocks. It is $208.02, -5.94%, with a $44.6B market cap. RSI is 55.9, neutral. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 55.9 Neutral
Market Cap $44.6B
Volume 1.5M
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-1.1B
EPS $-5.37
P/E Ratio -38.7x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Cislini Jeff | General Counsel | Sell | 56,894 | $209.24 | $11.9M | 2026 Aug 21 |
| Goldsmith Mark A | Insider | Sell | 86,000 | $209.20 | $18.0M | 2026 Aug 21 |
| Patel Sushil | Insider | Sell | 5,580 | $187.99 | $1.0M | 2026 Jun 29 |
| Anders Jack | Chief Financial Officer | Sell | 20,000 | $168.33 | $3.4M | 2026 Jun 24 |
| Horn Margaret A | Chief Operating Officer | Sell | 93,575 | $160.00 | $15.0M | 2026 Jun 17 |
| Mancini Anthony | Insider | Sell | 4,615 | $156.12 | $720,490 | 2026 Jun 16 |
| Goldsmith Mark A | Insider | Sell | 10,020 | $156.12 | $1.6M | 2026 Jun 16 |
| Cislini Jeff | General Counsel | Sell | 2,157 | $156.12 | $336,749 | 2026 Jun 16 |
| Anders Jack | Chief Financial Officer | Sell | 2,722 | $156.12 | $424,956 | 2026 Jun 16 |
| Kelsey Stephen Michael | Insider | Sell | 4,175 | $156.12 | $651,798 | 2026 Jun 16 |
| Horn Margaret A | Chief Operating Officer | Sell | 10,000 | $148.01 | $1.5M | 2026 Jun 11 |
| Mancini Anthony | Insider | Sell | 3,121 | $153.99 | $480,611 | 2026 May 26 |
| Mancini Anthony | Insider | Sell | 3,120 | $132.41 | $413,129 | 2026 Apr 27 |
| Goldsmith Mark A | Insider | Sell | 120,000 | $150.09 | $18.0M | 2026 Apr 15 |
| Mancini Anthony | Insider | Sell | 37,450 | $95.56 | $3.6M | 2026 Mar 25 |
| Cislini Jeff | General Counsel | Sell | 2,958 | $98.68 | $291,890 | 2026 Mar 19 |
| Wei Lin | Chief Medical Officer | Sell | 2,073 | $99.48 | $206,223 | 2026 Mar 17 |
| Kelsey Stephen Michael | Insider | Sell | 4,302 | $99.48 | $427,965 | 2026 Mar 17 |
| Goldsmith Mark A | Insider | Sell | 12,871 | $99.48 | $1.3M | 2026 Mar 17 |
| Horn Margaret A | Chief Operating Officer | Sell | 4,583 | $99.48 | $455,919 | 2026 Mar 17 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $1,023.96 | 63.8 | -- |
| | $141.42 | 61.5 | $8.9B |
| | $102.12 | 51.7 | -- |
| | $134.97 | 69.6 | $10.2B |
| | $105.31 | 69.1 | $12.0B |
Take RVMD further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put RVMD in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Revolution Medicines, Inc. next reports.
Set alerts on RVMD
Get notified when Revolution Medicines, Inc. hits your price targets or technical conditions are met.
Get Started Free